TuHURA Biosciences
HURA
14 hedge funds and large institutions have $162K invested in TuHURA Biosciences in 2024 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 2 reducing their positions, and 6 closing their positions.
100% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 2
0% more ownership
Funds ownership: 0.04% → 0.04% (+0%)
18% less funds holding
Funds holding: 17 → 14 (-3)
26% less capital invested
Capital invested by funds: $219K → $162K (-$57K)
50% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 6
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Geode Capital Management
Boston,
Massachusetts
|
+$21.4K |
| 2 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
+$17K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$5.94K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$3.92K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$1.73K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
XT
XTX Topco
George Town,
Cayman Islands
|
-$20K |
| 2 |
Jane Street
New York
|
-$12.9K |
| 3 |
LFAS
Level Four Advisory Services
Dallas,
Texas
|
-$12.1K |
| 4 |
IWC
Integrated Wealth Concepts
Waltham,
Massachusetts
|
-$5.94K |
| 5 |
BBA
Baader Bank Aktiengesellschaft
Unterschleissheim,
Germany
|
-$5.86K |
HURA Hedge Fund Activity: Q3 2024 in Review
14 of the 6,965 institutional investors tracked by Wall St. Rank reported a position in TuHURA Biosciences (HURA) for Q3 2024, worth a combined $162K — down 26% from $219K a quarter earlier.
Sellers outnumbered buyers: 6 funds closed out of HURA and 3 opened new positions — a net loss of 3 holders — while 2 trimmed existing stakes and 4 added.
The largest buyer was Geode Capital Management, adding an estimated $21.4K. The largest seller was XTX Topco, exiting entirely with an estimated $20K sold.
- 14 institutional investors held TuHURA Biosciences (HURA) as of Q3 2024, down from 17 in Q2 2024.
- Funds reported $162K of TuHURA Biosciences stock for Q3 2024, down 26% quarter-over-quarter.
- 3 funds opened new TuHURA Biosciences positions in Q3 2024 and 6 closed out, a net change of -3 holders.
- The largest TuHURA Biosciences buyer in Q3 2024 was Geode Capital Management, an estimated $21.4K added.
- The largest TuHURA Biosciences seller in Q3 2024 was XTX Topco, an estimated $20K sold.
Based on aggregated 13F filings for Q3 2024.